Metastatic epidural spinal cord compression: update on management.

Semin Oncol

Department of Neurology and Health Sciences Technology, Harvard Medical School and Massachusetts General Hospital, Boston, 02114, USA.

Published: June 2006

AI Article Synopsis

  • Recent advancements in imaging, prognostic factors, and treatment techniques have changed the approach to managing metastatic epidural spinal cord compression (MESCC).
  • Patients are no longer uniformly treated with corticosteroids and radiotherapy; instead, management should be tailored to individual circumstances.
  • The text also includes a historical overview of how MESCC management has evolved over time.

Article Abstract

Until recently, patients with metastatic epidural spinal cord compression (MESCC) were routinely treated with corticosteroids and radiotherapy (RT). However, major advances in imaging, recognition of new prognostic factors, and new techniques in RT and surgery have led to a number of management choices that need to be considered when treating a patient with MESCC. In our view, the management should be individualized taking into account many variables. We present here some of the advances we believe are among the most important. A historical background to the modern management of this condition is first presented.

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2006.03.002DOI Listing

Publication Analysis

Top Keywords

metastatic epidural
8
epidural spinal
8
spinal cord
8
cord compression
8
compression update
4
management
4
update management
4
management patients
4
patients metastatic
4
compression mescc
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!